# Arnuity® Ellipta® Drug Use Investigation

> **NCT03184480** · — · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 336 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Arnuity Ellipta

## Key facts

- **NCT ID:** NCT03184480
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-08-19
- **Primary completion:** 2021-03-17
- **Final completion:** 2021-03-17
- **Target enrollment:** 336 (ACTUAL)
- **Last updated:** 2021-04-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03184480

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03184480, "Arnuity® Ellipta® Drug Use Investigation". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03184480. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*